More human studies are necessary to determine its safety profile
BPC-157 was initially investigated for preventing and managing stomach ulcers, and further research delved into its potential for improving wound and injury healing in test subjects [3]
In the European Union , it's regulated under each member state's pharmaceutical laws but is generally not approved for human use
Your prescriber may keep you at the initial daily SubQ level longer or step you up, depending on your goals and how you feel during and after administrations
A 2025 systematic review in orthopedic sports medicine concluded that BPC-157 promotes healing by boosting growth factors and reducing inflammation, with improved structural and functional recovery across fracture, muscle, tendon, and ligament injury models
While not immune to digestive breakdown, BPC-157 survives longer than many peptides would under similar conditions